In 1987, Hachinski et al . [1] proposed Leukoaraiosis (LA) as an imaging academic term. Since then, LA and other cerebrovascular diseases have become the research focus of scholars at home and abroad. However, the molecular, cellular and pathogenesis of cerebrovascular disease are still unclear. Cerebral small vessel disease is caused by the lesions of perforating arteries, capillaries and veins of the brain. Modern imaging technology makes it possible to classify these diseases that can not be directly distinguished in clinical practice. The imaging features of cerebral infarction include cerebral microvascular atrophy. At present, a large number of studies have been carried out around LA, such as the pathogenesis, risk factors, imaging manifestations and classification, pathophysiological changes, hemodynamics, gene polymorphism and so on. In addition, although LA belongs to the category of cerebral small vessel disease, more scholars believe that there are countless links between large artery atherosclerosis and LA, and to some extent, have the same pathogenesis. This paper reviews the following aspects.
KeywordsLeukoaraiosis (LA)Cerebral Small Vessel DiseaseLarge Artery Atherosclerosis
Hachinski, V.C., Potter, P. and Merskey, H. (1987) Leuko-Araiosis. Archives of Neurology, 44, 21-23. https://doi.org/10.1001/archneur.1987.00520130013009
Raman, M.R., Kantarci, K., Murray, M.E., Jack, C.R. and Vemuri, P. (2016) Imaging Markers of Cerebrovascular Pathologies: Pathophysiology, Clinical Presentation, and Risk Factors. Alzheimer’s & Dementia, 5, 5-14. https://doi.org/10.1016/j.dadm.2016.12.006
Barkovich, A.J. and Deon, S. (2016) Hypomyelinating Disorders: An MRI Approach. Neurobiology of Disease, 87, 50-58. https://doi.org/10.1016/j.nbd.2015.10.015
Lin, Q., Huang, W.Q. and Tzeng, C.M. (2015) Genetic Associations of Leukoaraiosis Indicate Pathophysiological Mechanisms in White Matter Lesions Etiology. Reviews in the Neurosciences, 26, 343-358. https://doi.org/10.1515/revneuro-2014-0082
Rowbotham, G.F. and Little, E. (1965) Circulations of the Cerebral Hemispheres. The British Journal of Surgery, 52, 8-21. https://doi.org/10.1002/bjs.1800520104
Ravens, J.R., Toole, J.F. and Hasegawa, T. (1968) Anastomoses in the Vascular Bed of the Human Cerebrum. Journal of Neuropathology and Experimental Neurology, 27, 123-124.
Markus, H.S., Lythgoe, D.J., Ostegaard, L., O’Sullivan, M. and Williams, S.C. (2000) Reduced Cerebral Blood Flow in White Matter in Ischaemic Leukoaraiosis Demonstrated Using Quantitative Exogenous Contrast Based Perfusion MRI. Journal of Neurology, Neurosurgery, and Psychiatry, 69, 48-53. https://doi.org/10.1136/jnnp.69.1.48
Lin, J., Wang, D., Lan, L. and Fan, Y. (2017) Multiple Factors Involved in the Pathogenesis of White Matter Lesions. BioMed Research International, 2017, Article ID: 9372050. https://doi.org/10.1155/2017/9372050
Chiu, A.F., Huang, M.H., Hsu, M.H., Liu, J.L. and Chiu, J.F. (2015) Association of Urinary Incontinence with Impaired Functional Status among Older People Living in a Long-Term Care Setting. Geriatrics & Gerontology International, 15, 296-301. https://doi.org/10.1111/ggi.12272
Cox, S.R., Bastin, M.E., Ferguson, K.J., Maniega, S.M., MacPherson, S.E., Deary, I.J., Wardlaw, J.M. and MacLullich, A.M. (2015) Brain White Matter Integrity and Cortisol in Older Men: The Lothian Birth Cohort 1936. Neurobiology of Aging, 36, 257-264. https://doi.org/10.1016/j.neurobiolaging.2014.06.022
Luciano, M., Marioni, R.E., Valdes Hernandez, M., Munoz Maniega, S., Hamilton, I.F., Royle, N.A., Chauhan, G., Bis, J., Debette, S., DeCarli, C., Fornage, M., Schmidt, R., Ikram, M.A., Launer, L.J., Seshadri, S., Bastin, M.E., Porteous, D.J., Wardlaw, J. and Deary, I.J. (2015) Structural Brain MRI Trait Polygenic Score Prediction of Cognitive Abilities. Twin Research and Human Genetics: The Official Journal of the International Society for Twin Studies, 18, 738-745. https://doi.org/10.1017/thg.2015.71
Rieckmann, A., Van Dijk, K.R., Sperling, R.A., Johnson, K.A., Buckner, R.L. and Hedden, T. (2016) Accelerated Decline in White Matter Integrity in Clinically Normal Individuals at Risk for Alzheimer’s Disease. Neurobiology of Aging, 42, 177-188. https://doi.org/10.1016/j.neurobiolaging.2016.03.016
Cheng, R., Qi, H., Liu, Y., Zhao, S. and Li, C. (2017) Abnormal Amplitude of Low-Frequency Fluctuations and Functional Connectivity of Resting-State Functional Magnetic Resonance Imaging in Patients with Leukoaraiosis. Brain and Behavior, 7, e00714. https://doi.org/10.1002/brb3.714
Li, R., Lai, Y., Zhang, Y., Yao, L. and Wu, X. (2017) Classification of Cognitive Level of Patients with Leukoaraiosis on the Basis of Linear and Non-Linear Functional Connectivity. Frontiers in Neurology, 8, Article 2. https://doi.org/10.3389/fneur.2017.00002
Sivakumar, L., Riaz, P., Kate, M., Jeerakathil, T., Beaulieu, C., Buck, B., Camicioli, R. and Butcher, K. (2017) White Matter Hyperintensity Volume Predicts Persistent Cognitive Impairment in Transient Ischemic Attack and Minor Stroke. International Journal of Stroke: Official Journal of the International Stroke Society, 12, 264-272. https://doi.org/10.1177/1747493016676612
Nam, K.W., Kwon, H.M., Lim, J.S., Han, M.K. and Lee, Y.S. (2017) Clinical Relevance of Abnormal Neuroimaging Findings and Long-Term Risk of Stroke Recurrence. European Journal of Neurology, 24, 1348-1354. https://doi.org/10.1111/ene.13391
Ryu, W.S., et al. (2017) Stroke Outcomes Are Worse with Larger Leukoaraiosis Volumes. Brain: A Journal of Neurology, 140, 158-170. https://doi.org/10.1093/brain/aww259
Arboix, A., Junqué, C., Arenaza-Urquijo, E.M., Rovira, M. and Bartrés-Faz, D. (2010) Progressive Gray Matter Atrophy in Lacunar Patients with Vascular Mild Cognitive Impairment Grau-Olivares. Cerebrovascular Diseases, 30, 157-166. https://doi.org/10.1159/000316059
Fazekas, F., Kleinert, R., Offenbacher, H., Schmidt, R., Kleinert, G., Payer, F., Radner, H. and Lechner, H. (1993) Pathologic Correlates of Incidental MRI White Matter Signal Hyperintensities. Neurology, 43, 1683-1689. https://doi.org/10.1212/WNL.43.9.1683
Guan, J., Yan, C., Gao, Q., et al. (2017) Analysis of Risk Factors in Patients with Leukoaraiosis. Medicine, 96, e6153. https://doi.org/10.1097/MD.0000000000006153
Leung, L.Y., Bartz, T.M., Rice, K., et al. (2017) Blood Pressure and Heart Rate Measures Associated with Increased Risk of Covert Brain Infarction and Worsening Leukoaraiosis in Older Adults. Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 1579-1586. https://doi.org/10.1161/ATVBAHA.117.309298
Cloonan, L., Fitzpatrick, K.M., Kanakis, A.S., et al. (2015) Metabolic Determinants of White Matter Hyperintensity Burden in Patients with Ischemic Stroke. Atherosclerosis, 240, 149-153. https://doi.org/10.1016/j.atherosclerosis.2015.02.052
Shi, J., Hao, K., Qi, P., et al. (2017) Confirmation of the Abnormal Lipid Metabolism as a Risk Factor for the Disease of Leukoaraiosis. Saudi Journal of Biological Sciences, 24, 508-513. https://doi.org/10.1016/j.sjbs.2017.01.020
Zhang, C.R., Cloonan, L., Fitzpatrick, K.M., et al. (2015) Determinants of White Matter Hyperintensity Burden Differ at the Extremes of Ages of Ischemic Stroke Onset. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 24, 649-654. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.10.016
Wei, C.C., Zhang, S.T., Liu, J.F., et al. (2017) Association between Fibrinogen and Leukoaraiosis in Patients with Ischemic Stroke and Atrial Fibrillation. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 26, 2630-2637. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.06.027
Li, J.J., Huang, Y.H., Lin, Y.Y., et al. (2017) The Association of Uric Acid with Leukoaraiosis. The Journal of International Medical Research, 45, 75-81. https://doi.org/10.1177/0300060516674353
Sachdev, P.S., Thalamuthu, A., Mather, K.A., et al. (2016) White Matter Hyperintensities Are under Strong Genetic Influence. Stroke, 47, 1422-1428. https://doi.org/10.1161/STROKEAHA.116.012532
Etherton, M.R., Wu, O., Cougo, P., et al. (2017) Structural Integrity of Normal Appearing White Matter and Sex-Specific Outcomes after Acute Ischemic Stroke. Stroke, 48, 3387-3389. https://doi.org/10.1161/STROKEAHA.117.019258
Schilling, S., Tzourio, C., Dufouil, C., et al. (2014) Plasma Lipids and Cerebral Small Vessel Disease. Neurology, 83, 1844-1852. https://doi.org/10.1212/WNL.0000000000000980
Chang, T.Y., Yamauchi, Y., Hasan, M.T. and Chang, C. (2017) Cellular Cholesterol Homeostasis and Alzheimer’s Disease. Journal of Lipid Research, 58, 2239-2254. https://doi.org/10.1194/jlr.R075630
Chandra, S.R., Christopher, R., Rajeswaran, J., et al. (2016) Factors Determining Cognitive Dysfunction in Cerebral Small Vessel Disease. Indian Journal of Psychological Medicine, 38, 56-61. https://doi.org/10.4103/0253-7176.175119
Saba, L., Sanfilippo, R., Balestrieri, A., et al. (2017) Relationship between Carotid Computed Tomography Dual-Energy and Brain Leukoaraiosis. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 26, 1824-1830. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.04.016
Moran, C., Phan, T.G. and Srikanth, V.K. (2012) Cerebral Small Vessel Disease: A Review of Clinical, Radiological, and Histopathological Phenotypes. International Journal of Stroke: Official Journal of the International Stroke Society, 7, 36-46. https://doi.org/10.1111/j.1747-4949.2011.00725.x
Manolio, T.A., Kronmal, R.A., Burke, G.L., et al. (1994) Magnetic Resonance Abnormalities and Cardiovascular Disease in Older Adults. The Cardiovascular Health Study. Stroke, 25, 318-327. https://doi.org/10.1161/01.STR.25.2.318
Ryu, W.S., et al. (2014) Grading and Interpretation of White Matter Hyperintensities Using Statistical Maps. Stroke, 45, 3567-3575. https://doi.org/10.1161/STROKEAHA.114.006662
Dickie, D.A., Aribisala, B., Mair, G., et al. (2017) Blood Pressure Variability and Leukoaraiosis in Acute Ischemic Stroke. International Journal of Stroke: Official Journal of the International Stroke Society, 13, 473-480. https://doi.org/10.1177/1747493017729267
Yano, Y., Butler, K.R., Hall, M.E., et al. (2017) Associations of Nocturnal Blood Pressure with Cognition by Self-Identified Race in Middle-Aged and Older Adults: The GENOA (Genetic Epidemiology Network of Arteriopathy) Study. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 6, e007022. https://doi.org/10.1161/JAHA.117.007022
Mok, V., Ding, D., Fu, J., et al. (2012) Transcranial Doppler Ultrasound for Screening Cerebral Small Vessel Disease: A Community Study. Stroke, 43, 2791-2793. https://doi.org/10.1161/STROKEAHA.112.665711
Poels, M.M., Zaccai, K., Verwoert, G.C., et al. (2012) Arterial Stiffness and Cerebral Small Vessel Disease: The Rotterdam Scan Study. Stroke, 43, 2637-2642. https://doi.org/10.1161/STROKEAHA.111.642264
Nasel, C., Boubela, R., Kalcher, K. and Moser, E. (2017) Normalised Time-to-Peak-Distribution Curves Correlate with Cerebral White Matter Hyperintensities—Could This Improve Early Diagnosis? Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 37, 444-455. https://doi.org/10.1177/0271678X16629485
Tsivgoulis, G., Katsanos, A.H., Papageorgiou, S.G., Dardiotis, E., Voumvourakis, K. and Giannopoulos, S. (2014) The Role of Neurosonology in the Diagnosis of Vascular Dementia. Journal of Alzheimer’s Disease: JAD, 42, S251-S257. https://doi.org/10.3233/JAD-132441
Barker, R., Wellington, D., Esiri, M.M. and Love, S. (2013) Assessing White Matter Ischemic Damage in Dementia Patients by Measurement of Myelin Proteins. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 33, 1050-1057. https://doi.org/10.1038/jcbfm.2013.46
Barker, R., Ashby, E.L., Wellington, D., et al. (2014) Pathophysiology of White Matter Perfusion in Alzheimer’s Disease and Vascular Dementia. Brain: A Journal of Neurology, 137, 1524-1532. https://doi.org/10.1093/brain/awu040
Farrall, A.J. and Wardlaw, J.M. (2009) Blood-Brain Barrier: Ageing and Microvascular Disease—Systematic Review and Meta-Analysis. Neurobiology of Aging, 30, 337-352. https://doi.org/10.1016/j.neurobiolaging.2007.07.015
Giwa, M.O., Williams, J., Elderfield, K., et al. (2012) Neuropathologic Evidence of Endothelial Changes in Cerebral Small Vessel Disease. Neurology, 78, 167-174. https://doi.org/10.1212/WNL.0b013e3182407968
Valdes Hernandez, M.D.C., Gonzalez-Castro, V., Chappell, F.M., et al. (2017) Application of Texture Analysis to Study Small Vessel Disease and Blood-Brain Barrier Integrity. Frontiers in Neurology, 8, Article 327. https://doi.org/10.3389/fneur.2017.00327
Tan, R., Traylor, M., Rutten-Jacobs, L. and Markus, H. (2017) New Insights into Mechanisms of Small Vessel Disease Stroke from Genetics. Clinical Science (London, England: 1979), 131, 515-531. https://doi.org/10.1042/CS20160825
Maccarrone, M., Ulivi, L., Giannini, N., et al. (2017) Endothelium and Oxidative Stress: The Pandora’s Box of Cerebral (and Non-Only) Small Vessel Disease? Current Molecular Medicine, 17, 169-180. https://doi.org/10.2174/1566524017666170822114739
Hassan, A., Hunt, B.J., O’Sullivan, M., et al. (2004) Homocysteine Is a Risk Factor for Cerebral Small Vessel Disease, Acting via Endothelial Dysfunction. Brain: A Journal of Neurology, 127, 212-219. https://doi.org/10.1093/brain/awh023
De Silva, T.M. and Miller, A.A. (2016) Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy? Frontiers in Pharmacology, 7, Article 61. https://doi.org/10.3389/fphar.2016.00061
Markus, H.S., Hunt, B., Palmer, K., Enzinger, C., Schmidt, H. and Schmidt, R. (2005) Markers of Endothelial and Hemostatic Activation and Progression of Cerebral White Matter Hyperintensities: Longitudinal Results of the Austrian Stroke Prevention Study. Stroke, 36, 1410-1414. https://doi.org/10.1161/01.STR.0000169924.60783.d4
Rosenberg, G.A., Bjerke, M. and Wallin, A. (2014) Multimodal Markers of Inflammation in the Subcortical Ischemic Vascular Disease Type of Vascular Cognitive Impairment. Stroke, 45, 1531-1538. https://doi.org/10.1161/STROKEAHA.113.004534
Seshadri, S., Wolf, P.A., Beiser, A.S., et al. (2008) Association of Plasma Total Homocysteine Levels with Subclinical Brain Injury: Cerebral Volumes, White Matter Hyperintensity, and Silent Brain Infarcts at Volumetric Magnetic Resonance Imaging in the Framingham Offspring Study. Archives of Neurology, 65, 642-649. https://doi.org/10.1001/archneur.65.5.642
Vilar-Bergua, A., Riba-Llena, I., Nafria, C., et al. (2016) Blood and CSF Biomarkers in Brain Subcortical Ischemic Vascular Disease: Involved Pathways and Clinical Applicability. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 36, 55-71. https://doi.org/10.1038/jcbfm.2015.68
Yoshida, M., Higashi, K., Kobayashi, E., et al. (2010) Correlation between Images of Silent Brain Infarction, Carotid Atherosclerosis and White Matter Hyperintensity, and Plasma Levels of Acrolein, IL-6 and CRP. Atherosclerosis, 211, 475-479. https://doi.org/10.1016/j.atherosclerosis.2010.03.031
Van Dijk, E.J., Prins, N.D., Vermeer, S.E., et al. (2005) C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study. Circulation, 112, 900-905. https://doi.org/10.1161/CIRCULATIONAHA.104.506337
Nam, K.W., Kwon, H.M., Jeong, H.Y., et al. (2017) High Neutrophil to Lymphocyte Ratio Is Associated with White Matter Hyperintensity in a Healthy Population. Journal of the Neurological Sciences, 380, 128-131. https://doi.org/10.1016/j.jns.2017.07.024
Aribisala, B.S., Wiseman, S., Morris, Z., et al. (2014) Circulating Inflammatory Markers Are Associated with Magnetic Resonance Imaging-Visible Perivascular Spaces but Not Directly with White Matter Hyperintensities. Stroke, 45, 605-607. https://doi.org/10.1161/STROKEAHA.113.004059
Wilkening, S.R., Lirette, S.T., Kullo, I.J., Turner, S.T., Griswold, M.E. and Mosley, T.H. (2016) Associations between Inflammation and Physical Function in African Americans and European Americans with Prevalent Cardiovascular Risk Factors. Journal of the American Geriatrics Society, 64, 1448-1455. https://doi.org/10.1111/jgs.14229
Kandel, B.M., Avants, B.B., Gee, J.C., et al. (2016) White Matter Hyperintensities Are More Highly Associated with Preclinical Alzheimer’s Disease than Imaging and Cognitive Markers of Neurodegeneration. Alzheimer’s & Dementia, 4, 18-27. https://doi.org/10.1016/j.dadm.2016.03.001
Gurol, M.E., Irizarry, M.C., Smith, E.E., et al. (2006) Plasma Beta-Amyloid and White Matter Lesions in AD, MCI, and Cerebral Amyloid Angiopathy. Neurology, 66, 23-29. https://doi.org/10.1212/01.wnl.0000191403.95453.6a
Gomis, M., Sobrino, T., Ois, A., et al. (2009) Plasma Beta-Amyloid 1-40 Is Associated with the Diffuse Small Vessel Disease Subtype. Stroke, 40, 3197-3201. https://doi.org/10.1161/STROKEAHA.109.559641
Moran, C., et al. (2012) Cerebral Small Vessel Disease: A Review of Clinical, Radiological, and Histopathological Phenotypes. International Journal of Stroke, 7, 36-46. https://doi.org/10.1111/j.1747-4949.2011.00725.x
Rudilosso, S., et al. (2022) The Potential Impact of Neuroimaging and Translational Research on the Clinical Management of Lacunar Stroke. International Journal of Molecular Sciences, 23, 1497. https://www.mdpi.com/1422-0067/23/3/1497 https://doi.org/10.3390/ijms23031497
Hilal, S., Akoudad, S., Van Duijn, C.M., et al. (2017) Plasma Amyloid-Beta Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study. Journal of Alzheimer’s Disease: JAD, 60, 977-987. https://doi.org/10.3233/JAD-170458
Van Dijk, E.J., Prins, N.D., Vermeer, S.E., et al. (2004) Plasma Amyloid Beta, Apolipoprotein E, Lacunar Infarcts, and White Matter Lesions. Annals of Neurology, 55, 570-575. https://doi.org/10.1002/ana.20050
Kaffashian, S., Tzourio, C., Soumare, A., et al. (2014) Plasma Beta-Amyloid and MRI Markers of Cerebral Small Vessel Disease: Three-City Dijon Study. Neurology, 83, 2038-2045. https://doi.org/10.1212/WNL.0000000000001038
Hassan, A., Lansbury, A., Catto, A.J., et al. (2002) Angiotensin Converting Enzyme Insertion/Deletion Genotype Is Associated with Leukoaraiosis in Lacunar Syndromes. Journal of Neurology, Neurosurgery, and Psychiatry, 72, 343-346. https://doi.org/10.1136/jnnp.72.3.343
Kehoe, P.G. (2018) The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress toward Disease Prevention and Treatment? Journal of Alzheimer’s Disease: JAD, 62, 1443-1466. https://doi.org/10.3233/JAD-171119
Brenner, D., Labreuche, J., Pico, F., et al. (2008) The Renin-Angiotensin-Aldosterone System in Cerebral Small Vessel Disease. Journal of Neurology, 255, 993-1000. https://doi.org/10.1007/s00415-008-0816-8
Jochemsen, H.M., Geerlings, M.I., Grool, A.M., et al. (2012) Angiotensin-Converting Enzyme and Progression of White Matter Lesions and Brain Atrophy—The SMART-MR Study. Journal of Alzheimer’s Disease: JAD, 29, 39-49. https://doi.org/10.3233/JAD-2012-111772
Nebes, R.D., Vora, I.J., Meltzer, C.C., et al. (2001) Relationship of Deep White Matter Hyperintensities and Apolipoprotein E Genotype to Depressive Symptoms in Older Adults without Clinical Depression. The American Journal of Psychiatry, 158, 878-884. https://doi.org/10.1176/appi.ajp.158.6.878
Van Rijn, M.J., Bos, M.J., Isaacs, A., et al. (2007) Polymorphisms of the Renin-Angiotensin System Are Associated with Blood Pressure, Atherosclerosis and Cerebral White Matter Pathology. Journal of Neurology, Neurosurgery, and Psychiatry, 78, 1083-1087. https://doi.org/10.1136/jnnp.2006.109819
Fornage, M., Chiang, Y.A., O’Meara, E., et al. (2008) Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study. Stroke, 39, 1952-1959. https://doi.org/10.1161/STROKEAHA.107.508135
Fernandez-Cadenas, I., Mendioroz, M., Domingues-Montanari, S., et al. (2011) Leukoaraiosis Is Associated with Genes Regulating Blood-Brain Barrier Homeostasis in Ischaemic Stroke Patients. European Journal of Neurology, 18, 826-835. https://doi.org/10.1111/j.1468-1331.2010.03243.x
Taylor, W.D., Zuchner, S., McQuoid, D.R., et al. (2008) The Brain-Derived Neurotrophic Factor VAL66MET Polymorphism and Cerebral White Matter Hyperintensities in Late-Life Depression. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 16, 263-271. https://doi.org/10.1097/JGP.0b013e3181591c30
Fornage, M., Mosley, T.H., Jack, C.R., et al. (2007) Family-Based Association Study of Matrix Metalloproteinase-3 and -9 Haplotypes with Susceptibility to Ischemic White Matter Injury. Human Genetics, 120, 671-680. https://doi.org/10.1007/s00439-006-0236-8
Smith, J.A., Turner, S.T., Sun, Y.V., et al. (2009) Complexity in the Genetic Architecture of Leukoaraiosis in Hypertensive Sibships from the GENOA Study. BMC Medical Genomics, 2, Article No. 16. https://doi.org/10.1186/1755-8794-2-16
Fornage, M., et al. (2011) Genome-Wide Association Studies of Cerebral White Matter Lesion Burden: The CHARGE Consortium. Annals of Neurology, 69, 928-939. https://doi.org/10.1002/ana.22403
Hofer, E., et al. (2015) White Matter Lesion Progression: Genome-Wide Search for Genetic Influences. Stroke, 46, 3048-3057. https://doi.org/10.1161/STROKEAHA.115.009252
Adib-Samii, P., et al. (2013) 17q25 Locus Is Associated with White Matter Hyperintensity Volume in Ischemic Stroke, but Not with Lacunar Stroke Status. Stroke, 44, 1609-1615. https://doi.org/10.1161/STROKEAHA.113.679936
Tabara, Y., Igase, M., Okada, Y., et al. (2013) Association of Chr17q25 with Cerebral White Matter Hyperintensities and Cognitive Impairment: The J-SHIPP Study. European Journal of Neurology, 20, 860-862. https://doi.org/10.1111/j.1468-1331.2012.03879.x
Schmidt, H., Zeginigg, M., Wiltgen, M., et al. (2011) Genetic Variants of the NOTCH3 Gene in the Elderly and Magnetic Resonance Imaging Correlates of Age-Related Cerebral Small Vessel Disease. Brain: A Journal of Neurology, 134, 3384-3397. https://doi.org/10.1093/brain/awr252
Rutten-Jacobs, L.C., Traylor, M., Adib-Samii, P., et al. (2015) Common NOTCH3 Variants and Cerebral Small-Vessel Disease. Stroke, 46, 1482-1487. https://doi.org/10.1161/STROKEAHA.114.008540
Willey, J.Z., Gardener, H., Moon, Y.P., et al. (2014) Lipid Profile Components and Subclinical Cerebrovascular Disease in the Northern Manhattan Study. Cerebrovascular Diseases (Basel, Switzerland), 37, 423-430. https://doi.org/10.1159/000362920
Lyall, D.M., Munoz Maniega, S., Harris, S.E., et al. (2015) APOE/TOMM40 Genetic Loci, White Matter Hyperintensities, and Cerebral Microbleeds. International Journal of Stroke: Official Journal of the International Stroke Society, 10, 1297-1300. https://doi.org/10.1111/ijs.12615
Wu, G., Cai, H., Cai, H., et al. (2016) Influence of the Cyclooxygenase-2 Gene -765G/C and -1195G/A Polymorphisms on Development of Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 25, 2126-2135. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.06.001
Hogh, P., Garde, E., Mortensen, E.L., Jorgensen, O.S., Krabbe, K. and Waldemar, G. (2007) The Apolipoprotein E Epsilon4-allele and Antihypertensive Treatment Are Associated with Increased Risk of Cerebral MRI White Matter Hyperintensities. Acta Neurologica Scandinavica, 115, 248-253. https://doi.org/10.1111/j.1600-0404.2006.00779.x
Godin, O., Tzourio, C., Maillard, P., Alperovitch, A., Mazoyer, B. and Dufouil, C. (2009) Apolipoprotein E Genotype Is Related to Progression of White Matter Lesion Load. Stroke, 40, 3186-3190. https://doi.org/10.1161/STROKEAHA.109.555839
Paternoster, L., Chen, W. and Sudlow, C.L. (2009) Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19,000 Subjects. Stroke, 40, 2020-2026. https://doi.org/10.1161/STROKEAHA.108.542050
Ritchie, S.J., Tucker-Drob, E.M., Cox, S.R., et al. (2017) Risk and Protective Factors for Structural Brain Ageing in the Eighth Decade of Life. Brain Structure & Function, 222, 3477-3490. https://doi.org/10.1007/s00429-017-1414-2
Sudre, C.H., Cardoso, M.J., Frost, C., et al. (2017) APOE epsilon4 Status Is Associated with White Matter Hyperintensities Volume Accumulation Rate Independent of AD Diagnosis. Neurobiology of Aging, 53, 67-75. https://doi.org/10.1016/j.neurobiolaging.2017.01.014
Rojas, S., Brugulat-Serrat, A., Bargallo, N., et al. (2017) Higher Prevalence of Cerebral White Matter Hyperintensities in Homozygous APOE-varepsilon4 Allele Carriers Aged 45 - 75: Results from the ALFA Study. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 38, 250-261. https://doi.org/10.1177/0271678X17707397
Schilling, S., et al. (2013) APOE Genotype and MRI Markers of Cerebrovascular Disease: Systematic Review and Meta-Analysis. Neurology, 81, 292-300. https://doi.org/10.1212/WNL.0b013e31829bfda4
Yadav, B.K. and Shin, B.S. (2015) Single-Nucleotide Polymorphisms of Tight Junction Component Claudin-1 Associated with Leukoaraiosis. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 24, 1662-1670. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.03.038
Yadav, B.K., Oh, S.Y., Kim, N.K. and Shin, B.S. (2014) Association of rs2075575 and rs9951307 Polymorphisms of AQP-4 Gene with Leukoaraiosis. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 23, 1199-1206. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.10.017
Qureischie, H., Heun, R., Popp, J., et al. (2009) Association of CETP Polymorphisms with the Risk of Vascular Dementia and White Matter Lesions. Journal of Neural Transmission (Vienna, Austria: 1996), 116, 467-472. https://doi.org/10.1007/s00702-008-0180-y
Amar, K., MacGowan, S., Wilcock, G., Lewis, T. and Scott, M. (1998) Are Genetic Factors Important in the Aetiology of Leukoaraiosis? Results from a Memory Clinic Population. International Journal of Geriatric Psychiatry, 13, 585-590. https://doi.org/10.1002/(SICI)1099-1166(199809)13:9 3.0.CO;2-0
Schmidt, R., Schmidt, H., Fazekas, F., et al. (2001) Angiotensinogen Polymorphism M235T, Carotid Atherosclerosis, and Small-Vessel Disease-Related Cerebral Abnormalities. Hypertension (Dallas, Tex: 1979), 38, 110-115. https://doi.org/10.1161/01.HYP.38.1.110
Henskens, L.H., Kroon, A.A., Van Boxtel, M.P., Hofman, P.A. and de Leeuw, P.W. (2005) Associations of the Angiotensin II Type 1 Receptor A1166C and the Endothelial NO Synthase G894T Gene Polymorphisms with Silent Subcortical White Matter Lesions in Essential Hypertension. Stroke, 36, 1869-1873. https://doi.org/10.1161/01.STR.0000177867.39769.cb
Taylor, W.D., Zhao, Z., Ashley-Koch, A., et al. (2013) Fiber Tract-Specific White Matter Lesion Severity Findings in Late-Life Depression and by AGTR1 A1166C Genotype. Human Brain Mapping, 34, 295-303. https://doi.org/10.1002/hbm.21445
Taylor, W.D., Steffens, D.C., Ashley-Koch, A., et al. (2010) Angiotensin Receptor Gene Polymorphisms and 2-Year Change in Hyperintense Lesion Volume in Men. Molecular Psychiatry, 15, 816-822. https://doi.org/10.1038/mp.2009.26
Verpillat, P., Alperovitch, A., Cambien, F., Besancon, V., Desal, H. and Tzourio, C. (2001) Aldosterone Synthase (CYP11B2) Gene Polymorphism and Cerebral White Matter Hyperintensities. Neurology, 56, 673-675. https://doi.org/10.1212/WNL.56.5.673
Kohara, K., Fujisawa, M. ando, F., et al. (2003) MTHFR Gene Polymorphism as a Risk Factor for Silent Brain Infarcts and White Matter Lesions in the Japanese General Population: The NILS-LSA Study. Stroke, 34, 1130-1135. https://doi.org/10.1161/01.STR.0000069163.02611.B0
Szolnoki, Z., Szaniszlo, I., Szekeres, M., et al. (2012) Evaluation of the MTHFR A1298C Variant in Leukoaraiosis. Journal of Molecular Neuroscience: MN, 46, 492-496. https://doi.org/10.1007/s12031-011-9621-4
Kumar, P., Yadav, A.K., Misra, S., Kumar, A., Chakravarty, K. and Prasad, K. (2016) Role of Interleukin-10 (-1082A/G) Gene Polymorphism with the Risk of Ischemic Stroke: A Meta-Analysis. Neurological Research, 38, 823-830. https://doi.org/10.1080/01616412.2016.1202395
Van Rossum, E.F., De Jong, F.J., Koper, J.W., et al. (2008) Glucocorticoid Receptor Variant and Risk of Dementia and White Matter Lesions. Neurobiology of Aging, 29, 716-723. https://doi.org/10.1016/j.neurobiolaging.2006.11.016
Verhaaren, B.F., et al. (2015) Multiethnic Genome-Wide Association Study of Cerebral White Matter Hyperintensities on MRI. Circulation Cardiovascular Genetics, 8, 398-409. https://doi.org/10.1161/CIRCGENETICS.114.000858
Huang, C.C., Liu, M.E., Chou, K.H., et al. (2014) Effect of BDNF Val66Met Polymorphism on Regional White Matter Hyperintensities and Cognitive Function in Elderly Males without Dementia. Psychoneuroendocrinology, 39, 94-103. https://doi.org/10.1016/j.psyneuen.2013.09.027
Szolnoki, Z., Kondacs, A., Mandi, Y. and Somogyvari, F. (2007) Evaluation of the Roles of the A185C and C406T Kinesin Light-Chain 1 Variants in the Development of Leukoaraiosis. Neuroscience Letters, 429, 101-104. https://doi.org/10.1016/j.neulet.2007.09.069
Van Rijn, M.J., Bos, M.J., Yazdanpanah, M., et al. (2006) Alpha-Adducin Polymorphism, Atherosclerosis, and Cardiovascular and Cerebrovascular Risk. Stroke, 37, 2930-2934. https://doi.org/10.1161/01.STR.0000248760.67039.2b
Schmidt, R., Schmidt, H., Fazekas, F., et al. (2000) MRI Cerebral White Matter Lesions and Paraoxonase PON1 Polymorphisms: Three-Year Follow-Up of the Austrian Stroke Prevention Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 1811-1816. https://doi.org/10.1161/01.ATV.20.7.1811
Hadjigeorgiou, G.M., Malizos, K., Dardiotis, E., et al. (2007) Paraoxonase 1 Gene Polymorphisms in Patients with Osteonecrosis of the Femoral Head with and without Cerebral White Matter Lesions. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society, 25, 1087-1093. https://doi.org/10.1002/jor.20393
Neurology Working Group of the Cohorts for H, Aging Research in Genomic Epidemiology Consortium tSGN, the International Stroke Genetics C (2016) Identification of Additional Risk Loci for Stroke and Small Vessel Disease: A Meta-Analysis of Genome-Wide Association Studies. The Lancet Neurology, 15, 695-707.
Tan, R.Y. and Markus, H.S. (2015) Monogenic Causes of Stroke: Now and the Future. Journal of Neurology, 262, 2601-2616. https://doi.org/10.1007/s00415-015-7794-4
Adib-Samii, P., Devan, W., Traylor, M., et al. (2015) Genetic Architecture of White Matter Hyperintensities Differs in Hypertensive and Nonhypertensive Ischemic Stroke. Stroke, 46, 348-353. https://doi.org/10.1161/STROKEAHA.114.006849
Mendonca, L., Mendes-Ferreira, P., Bento-Leite, A., et al. (2014) Angiotensin-(1-7) Modulates Angiotensin II-Induced Vasoconstriction in Human Mammary Artery. Cardiovascular Drugs and Therapy, 28, 513-522. https://doi.org/10.1007/s10557-014-6555-4
Gao, T., Huang, L., Fu, Q. and Bai, Y. (2015) Association of Polymorphisms in the AGT Gene (M235T, T174M) with Ischemic Stroke in the Chinese Population. Journal of the Renin-Angiotensin-Aldosterone System: JRAAS, 16, 681-686. https://doi.org/10.1177/1470320315583600
Samani, N.J. (1991) Molecular Biology of the Renin-Angiotensin System: Implications for Hypertension and Beyond. Journal of Cardiovascular Pharmacology, 18, S1-S6. https://doi.org/10.1097/00005344-199106182-00002
Salminen, L.E., Schofield, P.R., Pierce, K.D., et al. (2016) Neuromarkers of the Common Angiotensinogen Polymorphism in Healthy Older Adults: A Comprehensive Assessment of White Matter Integrity and Cognition. Behavioural Brain Research, 296, 85-93. https://doi.org/10.1016/j.bbr.2015.08.028
Salminen, L.E., Schofield, P.R., Pierce, K.D., et al. (2014) Impact of the AGTR1 A1166C Polymorphism on Subcortical Hyperintensities and Cognition in Healthy Older Adults. Age, 36, 9664. https://doi.org/10.1007/s11357-014-9664-x
Yuan, H., Wang, X., Xia, Q., Ge, P., Wang, X. and Cao, X. (2015) Angiotensin Converting Enzyme (I/D) Gene Polymorphism Contributes to Ischemic Stroke Risk in Caucasian Individuals: A Meta-Analysis Based on 22 Case-Control Studies. The International Journal of Neuroscience, 126, 488-498. https://doi.org/10.3109/00207454.2015.1036421
Assareh, A.A., Mather, K.A., Crawford, J.D., et al. (2014) Renin-Angiotensin System Genetic Polymorphisms and Brain White Matter Lesions in Older Australians. American Journal of Hypertension, 27, 1191-1198. https://doi.org/10.1093/ajh/hpu035
Gormley, K., Bevan, S. and Markus, H.S. (2007) Polymorphisms in Genes of the Renin-Angiotensin System and Cerebral Small Vessel Disease. Cerebrovascular Diseases (Basel, Switzerland), 23, 148-155. https://doi.org/10.1159/000097052
Rutten-Jacobs, L.C., Traylor, M., Adib-Samii, P., et al. (2016) Association of MTHFR C677T Genotype with Ischemic Stroke Is Confined to Cerebral Small Vessel Disease Subtype. Stroke, 47, 646-651. https://doi.org/10.1161/STROKEAHA.115.011545
Tran, T., Cotlarciuc, I., Yadav, S., et al. (2016) Candidate-Gene Analysis of White Matter Hyperintensities on Neuroimaging. Journal of Neurology, Neurosurgery, and Psychiatry, 87, 260-266. https://doi.org/10.1136/jnnp-2014-309685
Huang, W.Q., Ye, H.M., Li, F.F., et al. (2016) Analysis of Genetic Polymorphisms Associated with Leukoaraiosis in the Southern Chinese Population: A Case-Control Study. Medicine, 95, e3857. https://doi.org/10.1097/MD.0000000000003857
Lu, H., Zhu, J., Zang, Y., Ze, Y. and Qin, J. (2006) Cloning, Purification, and Refolding of Human Paraoxonase-3 Expressed in Escherichia coli and Its Characterization. Protein Expression and Purification, 46, 92-99. https://doi.org/10.1016/j.pep.2005.07.021
Shan, X.Y., Chen, G.Z., Cheng, G.P. and Tao, H.M. (2013) Cyclooxygenase 2 Genetic Polymorphism May Increase the Risk of Developing Leukoaraiosis in Chinese. Journal of Molecular Neuroscience: MN, 51, 461-466. https://doi.org/10.1007/s12031-013-0066-9
Yao, M., Lv, D., Huo, J. and Sun, Z. (2017) Cerebral Small Vessel Disease Is Associated with Genetic Variations in CYP2J. Current Neurovascular Research, 14, 378-384. https://doi.org/10.2174/1567202614666171017151128
Konnecke, H. and Bechmann, I. (2013) The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas. Clinical & Developmental Immunology, 2013, Article ID: 914104. https://doi.org/10.1155/2013/914104
Romero, J.R., Vasan, R.S., Beiser, A.S., et al. (2010) Association of Matrix Metalloproteinases with MRI Indices of Brain Ischemia and Aging. Neurobiology of Aging, 31, 2128-2135. https://doi.org/10.1016/j.neurobiolaging.2008.11.004
Zhang, M., Zhu, W., Yun, W., et al. (2015) Correlation of Matrix Metalloproteinase-2 Single Nucleotide Polymorphisms with the Risk of Small Vessel Disease (SVD). Journal of the Neurological Sciences, 356, 61-64. https://doi.org/10.1016/j.jns.2015.04.056
Altmann, M., Thommessen, B., Ronning, O.M., Benth, J.S., Reichenbach, A.S. and Fure, B. (2016) Middle Cerebral Artery Pulsatility Index Is Associated with Cognitive Impairment in Lacunar Stroke. Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging, 26, 431-435. https://doi.org/10.1111/jon.12335
Fisse, A.L., Pueschel, J., Deppe, M., Ringelstein, E.B. and Ritter, M.A. (2016) TCD-Profiling Using AVERAGE. A New Technique to Evaluate Transcranial Doppler Ultrasound Flow Spectra of Subjects with Cerebral Small Vessel Disease. Cerebrovascular Diseases (Basel, Switzerland), 41, 50-59. https://doi.org/10.1159/000441921
Lee, W.J., Jung, K.H., Ryu, Y.J., et al. (2017) Progression of Cerebral White Matter Hyperintensities and the Associated Sonographic Index. Radiology, 284, 824-833. https://doi.org/10.1148/radiol.2017162064
Su, Y.C., Lim, S.N., Yang, F.Y. and Lin, S.K. (2017) Evaluation of Cerebral Blood Flow in Acute Ischemic Stroke Patients with Atrial Fibrillation: A Sonographic Study. Journal of the Formosan Medical Association, 116, 287-294. https://doi.org/10.1016/j.jfma.2016.05.009
Hamel, E. (2006) Perivascular Nerves and the Regulation of Cerebrovascular Tone. Journal of Applied Physiology (Bethesda, Md: 1985), 100, 1059-1064. https://doi.org/10.1152/japplphysiol.00954.2005
Smolinski, L. and Czlonkowska, A. (2016) Cerebral Vasomotor Reactivity in Neurodegenerative Diseases. Neurologia i Neurochirurgia Polska, 50, 455-462. https://doi.org/10.1016/j.pjnns.2016.07.011
Etherton, M.R., Wu, O., Cougo, P., et al. (2017) Integrity of Normal-Appearing White Matter and Functional Outcomes after Acute Ischemic Stroke. Neurology, 88, 1701-1708. https://doi.org/10.1212/WNL.0000000000003890
Arba, F., Mair, G., Carpenter, T., et al. (2017) Cerebral White Matter Hypoperfusion Increases with Small-Vessel Disease Burden. Data from the Third International Stroke Trial. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 26, 1506-1513. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.03.002
Turk, M., Zaletel, M. and Pretnar Oblak, J. (2016) Characteristics of Cerebral Hemodynamics in Patients with Ischemic Leukoaraiosis and New Ultrasound Indices of Ischemic Leukoaraiosis. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 25, 977-984. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.12.045
Intharakham, K., Suwanprasert, K. and Muengtaweepongsa, S. (2017) Correlation between Decreased Parasympathetic Activity and Reduced Cerebrovascular Reactivity in Patients with Lacunar Infarct. Current Neurovascular Research, 14, 65-70. https://doi.org/10.2174/1570159X14666161213122500
Bohr, I., McDonald, C., He, J., Kerr, S., Newton, J.L. and Blamire, A.M. (2015) Brain Oxygenation Responses to an Autonomic Challenge: A Quantitative fMRI Investigation of the Valsalva Manoeuvre. AGE, 37, Article No. 91. https://doi.org/10.1007/s11357-015-9833-6
Blair, G.W., Doubal, F.N., Thrippleton, M.J., Marshall, I. and Wardlaw, J.M. (2016) Magnetic Resonance Imaging for Assessment of Cerebrovascular Reactivity in Cerebral Small Vessel Disease: A Systematic Review. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 36, 833-841. https://doi.org/10.1177/0271678X16631756
Shi, Y., Thrippleton, M.J., Makin, S.D., et al. (2016) Cerebral Blood Flow in Small Vessel Disease: A Systematic Review and Meta-Analysis. Journal of Cerebral Blood Flow & Metabolism, 36, 1653-1667. https://doi.org/10.1177/0271678X16662891
Bernbaum, M., Menon, B.K., Fick, G., et al. (2015) Reduced Blood Flow in Normal White Matter Predicts Development of Leukoaraiosis. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 35, 1610-1615. https://doi.org/10.1038/jcbfm.2015.92
Hainsworth, A.H., Minett, T. andoh, J., et al. (2017) Neuropathology of White Matter Lesions, Blood-Brain Barrier Dysfunction, and Dementia. Stroke, 48, 2799-2804. https://doi.org/10.1161/STROKEAHA.117.018101
Bang, O.Y., Chung, J.W., Ryoo, S., et al. (2016) Brain Microangiopathy and Macroangiopathy Share Common Risk Factors and Biomarkers. Atherosclerosis, 246, 71-77. https://doi.org/10.1016/j.atherosclerosis.2015.12.040
Holliday, E.G., et al. (2015) Genetic Overlap between Diagnostic Subtypes of Ischemic Stroke. Stroke, 46, 615-619. https://doi.org/10.1161/STROKEAHA.114.007930
Ishikawa, M., Sugawara, H., Tsuji, T., et al. (2017) Clinical Significance of the Coexistence of Carotid Artery Plaque and White Matter Disease in Patients with Symptomatic Cerebral Infarction. Clinical Neurology and Neurosurgery, 163, 179-185. https://doi.org/10.1016/j.clineuro.2017.10.027
Liao, S.Q., Li, J.C., Zhang, M., et al. (2015) The Association between Leukoaraiosis and Carotid Atherosclerosis: A Systematic Review and Meta-Analysis. The International Journal of Neuroscience, 125, 493-500. https://doi.org/10.3109/00207454.2014.949703
Ferreira, J.P., Kearney Schwartz, A., et al. (2017) Memory Alterations and White Matter Hyperintensities in Elderly Patients with Hypertension: The ADELAHYDE-2 Study. Journal of the American Medical Directors Association, 18, 451.E413-451.E 425. https://doi.org/10.1016/j.jamda.2017.01.008
Pantoni, L., Rossi, R., Inzitari, D., et al. (2000) Efficacy and Safety of Nimodipine in Subcortical Vascular Dementia: A Subgroup Analysis of the Scandinavian Multi-Infarct Dementia Trial. Journal of the Neurological Sciences, 175, 124-134. https://doi.org/10.1016/S0022-510X(00)00300-2
White, W.B., Marfatia, R., Schmidt, J., et al. (2013) Intensive versus Standard Ambulatory Blood Pressure Lowering to Prevent Functional Decline in the Elderly (Infinity). American Heart Journal, 165, 258-265e251. https://doi.org/10.1016/j.ahj.2012.11.008
Abraham, H.M., Wolfson, L., Moscufo, N., Guttmann, C.R., Kaplan, R.F. and White, W.B. (2016) Cardiovascular Risk Factors and Small Vessel Disease of the Brain: Blood Pressure, White Matter Lesions, and Functional Decline in Older Persons. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 36, 132-142. https://doi.org/10.1038/jcbfm.2015.121
Kokubo, M., Shimizu, A., Mitsui, T., et al. (2015) Impact of Night-Time Blood Pressure on Cerebral White Matter Hyperintensity in Elderly Hypertensive Patients. Geriatrics & Gerontology International, 15, 59-65. https://doi.org/10.1111/ggi.12662
Jochemsen, H.M., Van Der Flier, W.M., et al. (2015) Angiotensin-Converting Enzyme in Cerebrospinal Fluid and Risk of Brain Atrophy. Journal of Alzheimer’s Disease: JAD, 44, 153-162. https://doi.org/10.3233/JAD-131496
Edwards, J.D., Ramirez, J., Callahan, B.L., et al. (2017) Antihypertensive Treatment Is Associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study. Journal of Alzheimer’s Disease: JAD, 59, 1113-1122. https://doi.org/10.3233/JAD-170238
Ho, J.K. and Nation, D.A. (2017) Alzheimer’s Disease Neuroimaging I. Memory Is Preserved in Older Adults Taking AT1 Receptor Blockers. Alzheimer’s Research & Therapy, 9, Article No. 33. https://doi.org/10.1186/s13195-017-0255-9
Fierini, F., Poggesi, A. and Pantoni, L. (2017) Leukoaraiosis as an Outcome Predictor in the Acute and Subacute Phases of Stroke. Expert Review of Neurotherapeutics, 17, 963-975. https://doi.org/10.1080/14737175.2017.1371013
Gilberti, N., Gamba, M., Premi, E., et al. (2017) Leukoaraiosis Is a Predictor of Futile Recanalization in Acute Ischemic Stroke. Journal of Neurology, 264, 448-452. https://doi.org/10.1007/s00415-016-8366-y
Kongbunkiat, K., Wilson, D., Kasemsap, N., et al. (2017) Leukoaraiosis, Intracerebral Hemorrhage, and Functional Outcome after Acute Stroke Thrombolysis. Neurology, 88, 638-645. https://doi.org/10.1212/WNL.0000000000003605
Demaerschalk, B.M., Kleindorfer, D.O., Adeoye, O.M., et al. (2016) Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 47, 581-641. https://doi.org/10.1161/STR.0000000000000086
Streifler, J. and Maillard, P. (2017) Thrombolysis for Acute Ischemic Stroke in Patients with Leukoaraiosis: Caution Needed. Neurology, 88, 612-613. https://doi.org/10.1212/WNL.0000000000003620